Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration

Table 4

Multivariate analysis of visual acuity score change (letters) from baseline at 6 months.

Predictors	Unstandardized coefficients 𝐵 (SE)	Standardized coefficients 𝐵	𝑡	𝑃
Age	−2.998 (1.347)	−0.188	−2.227	0.028
Baseline VA score	−4.561 (1.217)	−0.303	−3.749	<0.001
Duration of neovascular AMD	−3.040 (1.290)	−0.193	−2.357	0.020
ARMS2 rs10490924	−3.593 (1.720)	−0.178	−2.090	0.039

AMD: age-related macular degeneration; SE: standard error; VA: visual acuity.
Variables included in step 1 are age group, gender, baseline VA score, duration of neovascular AMD, ARMS2 rs10490924 genotype, and treatment regimen.